Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
A technical investigation has identified oxoid columbia blood agar base cm0331t lot 1857212 used to make prepared media mp035 i various batches (annex i) may not provide acceptable microbiological performance when supplemented with whole horse or sheep blood. recovery is lower than typically expected and haemolvsis may be reduced atypical or absent.